Flow in a fibril-forming disease

In this issue of Blood, Muchtar and colleagues report on the prognostic value of multiparametric flow cytometry (MFC) to measure clonal plasma cell burden at diagnosis and at end of treatment in patients with amyloid light-chain (AL) amyloidosis.

Saved in:
Bibliographic Details
Main Authors: Schönland, Stefan (Author) , Hegenbart, Ute (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Blood
Year: 2017, Volume: 129, Issue: 1, Pages: 7-8
ISSN:1528-0020
DOI:10.1182/blood-2016-11-746693
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2016-11-746693
Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/129/1/7
Get full text
Author Notes:Stefan Schönland and Ute Hegenbart
Description
Summary:In this issue of Blood, Muchtar and colleagues report on the prognostic value of multiparametric flow cytometry (MFC) to measure clonal plasma cell burden at diagnosis and at end of treatment in patients with amyloid light-chain (AL) amyloidosis.
Item Description:Gesehen am 11.07.2018
Physical Description:Online Resource
ISSN:1528-0020
DOI:10.1182/blood-2016-11-746693